{"nct_id":"NCT02610777","title":"An Efficacy and Safety Study of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine in Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML) and Low-Blast Acute Myelogenous Leukemia (AML)","status":"COMPLETED","status_verified_date":"2022-08","start_date":"2016-04-14","start_date_type":"ACTUAL","primary_completion_date":"2019-09-04","primary_completion_date_type":"ACTUAL","completion_date":"2021-07-23","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["TAK"]}